5.7 KiB
| title | chunk | source | category | tags | date_saved | instance |
|---|---|---|---|---|---|---|
| COVAX | 3/3 | https://en.wikipedia.org/wiki/COVAX | reference | science, encyclopedia | 2026-05-05T12:43:59.702098+00:00 | kb-cron |
=== China === China joined COVAX on 9 October 2020. The Sinopharm BIBP vaccine and CoronaVac (by Sinovac Biotech) are Chinese-developed vaccines approved by the WHO for distribution through COVAX. By July 2021, GAVI had signed advanced purchase agreements for 170 million doses of the Sinopharm BIBP vaccine, 350 million doses of CoronaVac, and 414 million doses of SCB-2019, another vaccine in Phase III trials. On 8 August 2021, China pledges US$100 million towards equitable access to COVID-19 vaccines for lower-income countries, brings the total raised for the Covax to nearly US$10 billion Further, China's Leader Xi Jinping pledges 2 billion vaccines globally through year's end. According to AP News, China has already delivered 770 million doses to foreign countries since September 2020 (as of 6 August 2021)
=== India === India joined COVAX through a membership with the GAVI alliance. The Serum Institute of India is the main producer for the Oxford–AstraZeneca vaccine, up to 700 million doses were expected for 2021. After initial deliveries to North Africa, West Africa, Eastern Europe and the Middle East in March and April 2021, India began to limit vaccine exports until the end of 2021, due to high domestic demand. Based on the high infection rates in India, COVAX was projected to deliver only 145 million doses instead of 240 million by May 2021. Vaccine production was also negatively affected because of a ban by the U.S. on the export of key raw materials. In September 2021, the Government of India announced the resumption of vaccines exports from October 2021 onwards since it had quadrupled its production and only excess supplies would be exported.
=== European Union === As of November 2020, the European Union (EU) and EU members have pledged €870 million to COVAX. The European Commission (EC) brought the EU into COVAX on 31 August 2020 and pledged €400 million in guarantees, but did not state how this money would be paid out or its conditions. The EC pledged a further €100 million from the 11th European Development Fund to COVAX via a grant to GAVI on 12 November. Individual EU member states have also made additional pledges; France donated an additional €100 million, Spain an additional €50 million, and Finland an additional €2 million. According to the Foreign Office of the Federal Republic of Germany, Germany has joined COVAX through the European Union and has pledged €300 million for the treatment of COVID-19 in developing nations bringing the total EU contribution to over €2.2 billion. On the consilium site, Team Europe reported a €2.47 billion donation. The Gavi COVAX Advance Market Commitment, a financing mechanism supported by donors and expedited by the European Investment Bank, provided free vaccinations to individuals in the world's 92 poorest countries. So far, more than 1.6 billion COVAX doses have been provided to poor nations, assisting in the vaccination of 52% of their population, compared to a global average of 64%.
=== United Kingdom === The United Kingdom has provided £548 million to Covax. The United Kingdom was the biggest single donor to COVAX-AMC until being overtaken by the European Union and the United States.
=== United States ===
As part of its America First policy, the Trump administration stated that it would not join COVAX because of its association with the WHO, from which it had begun a year-long withdrawal process on 6 July 2020. After Joe Biden was elected president in the 2020 election, he announced that the United States would remain in the WHO and would join COVAX on 20 January 2021. This reversal of American policy (announced by Anthony Fauci, Chief Medical Advisor to the President) was welcomed globally. On 19 February, the US pledged $4 billion, making it the single largest contributor to the fund. On 16 July 2021, the African Union (AU)/African Vaccine Acquisition Trust (AVAT), COVAX and the United States government announced the donation of 25 million Johnson & Johnson COVID-19 vaccines to 49 African countries. Afreximbank put in place a US$2 billion Advance Procurement Commitment (APC) Guarantee to obtain 400 million more doses of the Johnson & Johnson COVID-19 vaccine, providing a total of 620 million doses to Africa by the end of 2021. The vaccines will be in part sourced from licensed production in South Africa, and distributed by COVAX with the goal to vaccinate 60% of the population.
=== United Arab Emirates === Since the UAE started producing Hayat-Vax in late March 2021, a rebranded version of the Chinese Sinopharm BIBP vaccine through a joint venture between Sinopharm and Group 42, the country has donated vaccine doses to several African countries.
=== Private donors === It is possible for private donors to donate to COVAX through the "Go Give One" campaign. The WHO estimates the campaign's cost-effectiveness at one vaccine dose per US$7 donated.
== Closure of the COVAX program == On 31 December 2023, the COVAX program was officially closed after delivering 2 billion doses of COVID-19 vaccines. The program was credited with having averted the deaths of 2.7 million people in lower-income countries and for many other around the world. After closure, lower-income economies were still able to receive COVID-19 vaccines via Gavi.
== See also == World Health Organization's response to the COVID-19 pandemic Medicines Patent Pool
== References ==
== External links ==
List of participants in the COVAX Facility, Confirmations of intent to participate and AMC-Eligible economies WHO information page about COVAX GAVI page about COVAX Archived 25 September 2020 at the Wayback Machine